{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:31:03Z","timestamp":1780482663667,"version":"3.54.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10835-2","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T05:00:41Z","timestamp":1752901241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Curcumin and Silibinin loaded pegylated nanoniosome for cancer therapy: bioinformatics and in vitro study"],"prefix":"10.1007","volume":"52","author":[{"given":"Mohammad Hosseini","family":"Hooshiar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz Shahi","family":"Khalaf Ansar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robab","family":"Shaghaghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhgan","family":"Banavand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh Abbasi","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Jahanban","family":"Esfahlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"10835_CR1","doi-asserted-by":"crossref","unstructured":"Zenjanab MK et al (2024) Paclitaxel for breast cancer therapy: a review on effective drug combination modalities and nano drug delivery platforms. J Drug Deliv Sci Technol,: p. 105567","DOI":"10.1016\/j.jddst.2024.105567"},{"issue":"1","key":"10835_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X et al (2025) Breast cancer: pathogenesis and treatments. Signal Transduct Target Therapy 10(1):49","journal-title":"Signal Transduct Target Therapy"},{"key":"10835_CR3","first-page":"45","volume-title":"In Silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens","author":"S Parvizpour","year":"2019","unstructured":"Parvizpour S et al (2019) In Silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens, vol 9. BI, BioImpacts, p 45. 1"},{"issue":"1","key":"10835_CR4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12935-024-03320-6","volume":"24","author":"T Nayerpour Dizaj","year":"2024","unstructured":"Nayerpour Dizaj T et al (2024) Significance of PSCA as a novel prognostic marker and therapeutic target for cancer. Cancer Cell Int 24(1):135","journal-title":"Cancer Cell Int"},{"key":"10835_CR5","unstructured":"Mazloomi M et al page Advanced drug delivery platforms target cancer stem cells."},{"key":"10835_CR6","doi-asserted-by":"crossref","unstructured":"Huang Z, Yu P, Tang J (2020) Characterization of triple-negative breast cancer MDA-MB-231 cell spheroid model. OncoTargets Therapy,: p. 5395\u20135405","DOI":"10.2147\/OTT.S249756"},{"key":"10835_CR7","doi-asserted-by":"crossref","first-page":"132940","DOI":"10.1016\/j.ijbiomac.2024.132940","volume":"272","author":"H Mahmudi","year":"2024","unstructured":"Mahmudi H et al (2024) Self-activating chitosan-based nanoparticles for sphingosin-1 phosphate modulator delivery and selective tumor therapy. Int J Biol Macromol 272:132940","journal-title":"Int J Biol Macromol"},{"key":"10835_CR8","doi-asserted-by":"crossref","unstructured":"Karimi S et al (2025) For and against tumor microenvironment: nanoparticle-based strategies for active cancer therapy. Mater Today Bio,: p. 101626","DOI":"10.1016\/j.mtbio.2025.101626"},{"issue":"1","key":"10835_CR9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11033-025-10241-8","volume":"52","author":"M Fakeri","year":"2025","unstructured":"Fakeri M et al (2025) Targeted apoptosis in breast cancer cells via niosome-mediated delivery of cyclophosphamide and sodium oxamate. Mol Biol Rep 52(1):139","journal-title":"Mol Biol Rep"},{"issue":"4","key":"10835_CR10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/nnm-2021-0334","volume":"17","author":"N Mousazadeh","year":"2022","unstructured":"Mousazadeh N et al (2022) Anticancer evaluation of methotrexate and curcumin-coencapsulated niosomes against colorectal cancer cell lines. Nanomedicine 17(4):201\u2013217","journal-title":"Nanomedicine"},{"issue":"10","key":"10835_CR11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/bioengineering10101159","volume":"10","author":"S Saharkhiz","year":"2023","unstructured":"Saharkhiz S, Zarepour A, Zarrabi A (2023) Empowering cancer therapy: comparing pegylated and non-PEGylated niosomes loaded with Curcumin and doxorubicin on MCF-7 cell line. Bioengineering 10(10):1159","journal-title":"Bioengineering"},{"key":"10835_CR12","doi-asserted-by":"crossref","first-page":"116951","DOI":"10.1016\/j.biopha.2024.116951","volume":"177","author":"S Alimohammadvand","year":"2024","unstructured":"Alimohammadvand S et al (2024) Recent advances in biomimetic cell membrane\u2013camouflaged nanoparticles for cancer therapy. Biomed Pharmacother 177:116951","journal-title":"Biomed Pharmacother"},{"key":"10835_CR13","unstructured":"Zenjanab MK et al (2024) Notch signaling suppression by golden phytochemicals: potential for Cancer therapy. Adv Pharm Bull,: p.\u2013"},{"issue":"6","key":"10835_CR14","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.7314\/APJCP.2013.14.6.3449","volume":"14","author":"M Nasiri","year":"2013","unstructured":"Nasiri M et al (2013) Curcumin and Silibinin inhibit telomerase expression in T47D human breast cancer cells. Asian Pac J Cancer Prev 14(6):3449\u20133453","journal-title":"Asian Pac J Cancer Prev"},{"key":"10835_CR15","doi-asserted-by":"crossref","first-page":"1349745","DOI":"10.3389\/fphar.2024.1349745","volume":"15","author":"PP Ray","year":"2024","unstructured":"Ray PP et al (2024) A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment. Front Pharmacol 15:1349745","journal-title":"Front Pharmacol"},{"key":"10835_CR16","doi-asserted-by":"crossref","unstructured":"Tuli HS et al (2021) Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Seminars in Cancer biology. Elsevier","DOI":"10.1016\/j.semcancer.2020.09.014"},{"issue":"2","key":"10835_CR17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.34172\/apb.2024.035","volume":"14","author":"MK Zenjanab","year":"2024","unstructured":"Zenjanab MK et al (2024) Notch signaling suppression by golden phytochemicals: potential for cancer therapy. Adv Pharm Bull 14(2):302","journal-title":"Adv Pharm Bull"},{"key":"10835_CR18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40199-018-0215-3","volume":"26","author":"F Davarpanah","year":"2018","unstructured":"Davarpanah F et al (2018) Magnetic delivery of antitumor carboplatin by using PEGylated-Niosomes. DARU J Pharm Sci 26:57\u201364","journal-title":"DARU J Pharm Sci"},{"issue":"2","key":"10835_CR19","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/bib\/bbaa257","volume":"22","author":"G Muzio","year":"2021","unstructured":"Muzio G, O\u2019Bray L, Borgwardt K (2021) Biological network analysis with deep learning. Brief Bioinform 22(2):1515\u20131530","journal-title":"Brief Bioinform"},{"issue":"5","key":"10835_CR20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.56499\/jppres23.1699_12.5.837","volume":"12","author":"INN Sihombing","year":"2024","unstructured":"Sihombing INN, Arsianti A (2024) Network Pharmacology prediction and molecular Docking analysis on the mechanism of Eugenol as a candidate against Estrogen receptor-positive breast cancer. J Pharm Pharmacognosy Res 12(5):837\u2013851","journal-title":"J Pharm Pharmacognosy Res"},{"key":"10835_CR21","doi-asserted-by":"crossref","unstructured":"Majeed A, Mukhtar S (2023) Protein\u2013Protein interaction network exploration using Cytoscape, in Protein-Protein interactions: methods and protocols. Springer, pp 419\u2013427","DOI":"10.1007\/978-1-0716-3327-4_32"},{"issue":"12","key":"10835_CR22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/biomedicines8120637","volume":"8","author":"T-H Pham","year":"2020","unstructured":"Pham T-H et al (2020) STAT3 and p53: dual target for cancer therapy. Biomedicines 8(12):637","journal-title":"Biomedicines"},{"issue":"5","key":"10835_CR23","doi-asserted-by":"crossref","first-page":"055015","DOI":"10.1088\/1748-605X\/ad5d9b","volume":"19","author":"M Sharifi-Azad","year":"2024","unstructured":"Sharifi-Azad M et al (2024) Codelivery of methotrexate and Silibinin by niosome nanoparticles for enhanced chemotherapy of CT26 colon cancer cells. Biomed Mater 19(5):055015","journal-title":"Biomed Mater"},{"issue":"9","key":"10835_CR24","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1021\/acsomega.3c09782","volume":"9","author":"M Kaveh Zenjanab","year":"2024","unstructured":"Kaveh Zenjanab M et al (2024) Hyaluronic Acid-Targeted niosomes for effective breast Cancer chemostarvation therapy. ACS Omega 9(9):10875\u201310885","journal-title":"ACS Omega"},{"issue":"7","key":"10835_CR25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12032-025-02796-0","volume":"42","author":"Z Hashemi","year":"2025","unstructured":"Hashemi Z et al (2025) Hyaluronic acid-modified theranostic niosomes for targeted Fingolimod delivery and Inhibition of triple-negative breast cancer metastasis. Med Oncol 42(7):256","journal-title":"Med Oncol"},{"issue":"2","key":"10835_CR26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s43440-023-00462-8","volume":"75","author":"R Shahbazi","year":"2023","unstructured":"Shahbazi R et al (2023) Design and optimization various formulations of pegylated Niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells. Pharmacol Rep 75(2):442\u2013455","journal-title":"Pharmacol Rep"},{"issue":"3","key":"10835_CR27","doi-asserted-by":"crossref","first-page":"035015","DOI":"10.1088\/1748-605X\/ad2ed5","volume":"19","author":"MK Zenjanab","year":"2024","unstructured":"Zenjanab MK et al (2024) Niosomes containing Paclitaxel and gold nanoparticles with different coating agents for efficient chemo\/photothermal therapy of breast cancer. Biomed Mater 19(3):035015","journal-title":"Biomed Mater"},{"issue":"suppl1","key":"10835_CR28","doi-asserted-by":"crossref","first-page":"D684","DOI":"10.1093\/nar\/gkm795","volume":"36","author":"M Kuhn","year":"2007","unstructured":"Kuhn M et al (2007) STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res 36(suppl1):D684\u2013D688","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10835_CR29","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"C UniProt","year":"2021","unstructured":"UniProt C (2021) UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res 49(D1):D480\u2013D489","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10835_CR30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","volume":"20","author":"D Otasek","year":"2019","unstructured":"Otasek D et al (2019) Cytoscape automation: empowering workflow-based network analysis. Genome Biol 20(1):185","journal-title":"Genome Biol"},{"key":"10835_CR31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molstruc.2019.01.042","volume":"1182","author":"A Sol\u00eds-G\u00f3mez","year":"2019","unstructured":"Sol\u00eds-G\u00f3mez A et al (2019) Characterizing the properties of anticancer Silibinin and Silybin B complexes with UV\u2013Vis, FT-IR, and Raman spectroscopies: A combined experimental and theoretical study. J Mol Struct 1182:109\u2013118","journal-title":"J Mol Struct"},{"key":"10835_CR32","doi-asserted-by":"crossref","unstructured":"Rohman A et al (2015) Analysis of curcumin in Curcuma longa and Curcuma xanthorriza using FTIR spectroscopy and chemometrics.","DOI":"10.3923\/rjmp.2015.179.186"},{"issue":"1","key":"10835_CR33","first-page":"19","volume":"1","author":"R Fugita","year":"2012","unstructured":"Fugita R et al (2012) Thermal behaviour of Curcumin. Braz J Therm Anal 1(1):19\u201323","journal-title":"Braz J Therm Anal"},{"issue":"7","key":"10835_CR34","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3390\/polym13071142","volume":"13","author":"P Uthaiwat","year":"2021","unstructured":"Uthaiwat P et al (2021) Characteristic evaluation of gel formulation containing niosomes of melatonin or its derivative and mucoadhesive properties using ATR-FTIR spectroscopy. Polymers 13(7):1142","journal-title":"Polymers"},{"issue":"1","key":"10835_CR35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/bm025689+","volume":"4","author":"P Kolhe","year":"2003","unstructured":"Kolhe P, Kannan RM (2003) Improvement in ductility of Chitosan through blending and copolymerization with PEG: FTIR investigation of molecular interactions. Biomacromolecules 4(1):173\u2013180","journal-title":"Biomacromolecules"},{"issue":"1","key":"10835_CR36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1155\/2011\/628790","volume":"8","author":"A Reddy Polu","year":"2011","unstructured":"Reddy Polu A, Kumar R (2011) Impedance spectroscopy and FTIR studies of PEG-Based polymer electrolytes. J Chem 8(1):347\u2013353","journal-title":"J Chem"},{"issue":"10","key":"10835_CR37","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/nano14100846","volume":"14","author":"L Baldino","year":"2024","unstructured":"Baldino L, Riccardi D, Reverchon E (2024) Production of pegylated Vancomycin-Loaded niosomes by a continuous supercritical CO2 assisted process. Nanomaterials 14(10):846","journal-title":"Nanomaterials"},{"key":"10835_CR38","doi-asserted-by":"crossref","first-page":"101669","DOI":"10.1016\/j.jcou.2021.101669","volume":"52","author":"L Baldino","year":"2021","unstructured":"Baldino L, Reverchon E (2021) Niosomes formation using a continuous supercritical CO2 assisted process. J CO2 Utilization 52:101669","journal-title":"J CO2 Utilization"},{"key":"10835_CR39","doi-asserted-by":"crossref","first-page":"129921","DOI":"10.1016\/j.colsurfa.2022.129921","volume":"654","author":"ME Rad","year":"2022","unstructured":"Rad ME et al (2022) Optimization of Curcumin loaded niosomes for drug delivery applications. Colloids Surf A 654:129921","journal-title":"Colloids Surf A"},{"issue":"03","key":"10835_CR40","first-page":"389","volume":"11","author":"V Mishra","year":"2020","unstructured":"Mishra V et al (2020) Niosomes: potential nanocarriers for drug delivery. J Pharm Clin Res 11(03):389\u2013394","journal-title":"J Pharm Clin Res"},{"key":"10835_CR41","doi-asserted-by":"crossref","first-page":"100672","DOI":"10.1016\/j.mtbio.2023.100672","volume":"20","author":"M Azizi","year":"2023","unstructured":"Azizi M et al (2023) Multifunctional nanostructures: intelligent design to overcome biological barriers. Mater Today Bio 20:100672","journal-title":"Mater Today Bio"},{"issue":"9","key":"10835_CR42","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/jps.20491","volume":"95","author":"B Shi","year":"2006","unstructured":"Shi B, Fang C, Pei Y (2006) Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. J Pharm Sci 95(9):1873\u20131887","journal-title":"J Pharm Sci"},{"issue":"1","key":"10835_CR43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12645-024-00252-8","volume":"15","author":"M Safari Sharafshadeh","year":"2024","unstructured":"Safari Sharafshadeh M et al (2024) Folic acid-functionalized pegylated niosomes co-encapsulated cisplatin and Doxoribicin exhibit enhanced anticancer efficacy. Cancer Nanotechnol 15(1):14","journal-title":"Cancer Nanotechnol"},{"key":"10835_CR44","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1208\/s12249-009-9325-z","volume":"10","author":"PS Jadon","year":"2009","unstructured":"Jadon PS et al (2009) Enhanced oral bioavailability of Griseofulvin via niosomes. AAPS PharmSciTech 10:1186\u20131192","journal-title":"AAPS PharmSciTech"},{"key":"10835_CR45","first-page":"1","volume":"32","author":"M Barani","year":"2021","unstructured":"Barani M et al (2021) In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes. J Mater Science: Mater Med 32:1\u201313","journal-title":"J Mater Science: Mater Med"},{"key":"10835_CR46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.msec.2018.09.026","volume":"94","author":"M Barani","year":"2019","unstructured":"Barani M et al (2019) In Silico and in vitro study of magnetic niosomes for gene delivery: the effect of ergosterol and cholesterol. Mater Sci Engineering: C 94:234\u2013246","journal-title":"Mater Sci Engineering: C"},{"issue":"1","key":"10835_CR47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13036-023-00375-3","volume":"17","author":"A Bakand","year":"2023","unstructured":"Bakand A et al (2023) Efficient targeting of HIF-1\u03b1 mediated by YC-1 and PX-12 encapsulated niosomes: potential application in colon cancer therapy. J Biol Eng 17(1):58","journal-title":"J Biol Eng"},{"issue":"4","key":"10835_CR48","first-page":"711","volume":"10","author":"MR Mozafari","year":"2005","unstructured":"Mozafari MR (2005) Liposomes: an overview of manufacturing techniques. Cell Mol Biology Lett 10(4):711","journal-title":"Cell Mol Biology Lett"},{"issue":"1\u20132","key":"10835_CR49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(98)00169-0","volume":"172","author":"IF Uchegbu","year":"1998","unstructured":"Uchegbu IF, Vyas SP (1998) Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172(1\u20132):33\u201370","journal-title":"Int J Pharm"},{"key":"10835_CR50","doi-asserted-by":"crossref","unstructured":"Seras-Cansell M, Ollivon M, Lesieur S (1996) Generation of non-ionic monoalkyl amphiphile-cholesterol vesicles: evidence of membrane impermeability to octyl glucoside. STP pharma sciences. 6(1):12\u201320","DOI":"10.1021\/la950276y"},{"key":"10835_CR51","doi-asserted-by":"crossref","first-page":"101715","DOI":"10.1016\/j.jddst.2020.101715","volume":"57","author":"I Akbarzadeh","year":"2020","unstructured":"Akbarzadeh I et al (2020) Optimized doxycycline-loaded Niosomal formulation for treatment of infection-associated prostate cancer: an in-vitro investigation. J Drug Deliv Sci Technol 57:101715","journal-title":"J Drug Deliv Sci Technol"},{"key":"10835_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0351-4","volume":"16","author":"A Alemi","year":"2018","unstructured":"Alemi A et al (2018) Paclitaxel and Curcumin coadministration in novel cationic pegylated Niosomal formulations exhibit enhanced synergistic antitumor efficacy. J Nanobiotechnol 16:1\u201320","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"10835_CR53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1567201816666191112113031","volume":"17","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M et al (2020) Nano-soldiers ameliorate Silibinin delivery: a review study. Curr Drug Deliv 17(1):15\u201322","journal-title":"Curr Drug Deliv"},{"key":"10835_CR54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejps.2016.09.002","volume":"95","author":"MI Khan","year":"2016","unstructured":"Khan MI, Madni A, Peltonen L (2016) Development and in-vitro characterization of Sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur J Pharm Sci 95:88\u201395","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10835_CR55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/08982104.2012.727422","volume":"23","author":"R Kamel","year":"2013","unstructured":"Kamel R, Basha M, Abd El-Alim SH (2013) Development of a novel vesicular system using a binary mixture of Sorbitan monostearate and polyethylene glycol fatty acid esters for rectal delivery of Rutin. J Liposome Res 23(1):28\u201336","journal-title":"J Liposome Res"},{"issue":"6","key":"10835_CR56","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/10962247.2013.778918","volume":"63","author":"Z Shi","year":"2013","unstructured":"Shi Z, Chen J, Yin X (2013) Effect of anionic\u2013nonionic-mixed surfactant micelles on solubilization of PAHs. J Air Waste Manag Assoc 63(6):694\u2013701","journal-title":"J Air Waste Manag Assoc"},{"key":"10835_CR57","doi-asserted-by":"crossref","first-page":"851242","DOI":"10.3389\/fphar.2022.851242","volume":"13","author":"T Rezaei","year":"2022","unstructured":"Rezaei T et al (2022) Folic acid-decorated ph-responsive nanoniosomes with enhanced endocytosis for breast cancer therapy: in vitro studies. Front Pharmacol 13:851242","journal-title":"Front Pharmacol"},{"issue":"1","key":"10835_CR58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jmhi.2012.10.005","volume":"7","author":"C Moorthi","year":"2013","unstructured":"Moorthi C, Kathiresan K (2013) Curcumin\u2013Piperine\/Curcumin\u2013Quercetin\/Curcumin\u2013Silibinin dual drug-loaded nanoparticulate combination therapy: A novel approach to target and treat multidrug-resistant cancers. J Med Hypotheses Ideas 7(1):15\u201320","journal-title":"J Med Hypotheses Ideas"},{"issue":"4","key":"10835_CR59","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/em.22363","volume":"61","author":"TM Barros","year":"2020","unstructured":"Barros TM et al (2020) Inhibition of urinary bladder cancer cell proliferation by Silibinin. Environ Mol Mutagen 61(4):445\u2013455","journal-title":"Environ Mol Mutagen"},{"issue":"6","key":"10835_CR60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12032-023-02032-7","volume":"40","author":"A Firouzi Amandi","year":"2023","unstructured":"Firouzi Amandi A et al (2023) Enhanced anti-cancer effect of artemisinin-and curcumin-loaded Niosomal nanoparticles against human colon cancer cells. Med Oncol 40(6):170","journal-title":"Med Oncol"},{"issue":"1","key":"10835_CR61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12645-025-00309-2","volume":"16","author":"N Asghari Moghaddam","year":"2025","unstructured":"Asghari Moghaddam N et al (2025) Enhanced anticancer efficacy of oxaliplatin-loaded pegylated niosomes in breast cancer treatment. Cancer Nanotechnol 16(1):16","journal-title":"Cancer Nanotechnol"},{"issue":"4","key":"10835_CR62","doi-asserted-by":"crossref","first-page":"e202301767","DOI":"10.1002\/cbdv.202301767","volume":"21","author":"H Riazi","year":"2024","unstructured":"Riazi H et al (2024) Preparation of the myricetin-loaded pegylated niosomes and evaluation of their in vitro anti\u2010cancer potentials. Chem Biodivers 21(4):e202301767","journal-title":"Chem Biodivers"},{"issue":"10","key":"10835_CR63","doi-asserted-by":"crossref","first-page":"e0291905","DOI":"10.1371\/journal.pone.0291905","volume":"18","author":"T Miyoshi","year":"2023","unstructured":"Miyoshi T et al (2023) Noncanonical mechanism of Nrf2 activation by Diacylglycerol polyethylene glycol adducts in normal human epidermal keratinocytes. PLoS ONE 18(10):e0291905","journal-title":"PLoS ONE"},{"issue":"1","key":"10835_CR64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1208\/s12249-022-02212-0","volume":"23","author":"I Akbarzadeh","year":"2022","unstructured":"Akbarzadeh I et al (2022) The optimized formulation of tamoxifen-loaded niosomes efficiently induced apoptosis and cell cycle arrest in breast cancer cells. AAPS PharmSciTech 23(1):57","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10835_CR65","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pi.5987","volume":"69","author":"B Massoumi","year":"2020","unstructured":"Massoumi B et al (2020) PEGylated Hollow pH-responsive polymeric nanocapsules for controlled drug delivery. J Polym Int 69(5):519\u2013527","journal-title":"J Polym Int"},{"issue":"4","key":"10835_CR66","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1557\/jmr.2020.3","volume":"35","author":"H Samadian","year":"2020","unstructured":"Samadian H et al (2020) A de Novo theranostic nanomedicine composed of pegylated graphene oxide and gold nanoparticles for cancer therapy. J Mater Res 35(4):430\u2013441","journal-title":"J Mater Res"},{"issue":"24","key":"10835_CR67","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","volume":"13","author":"L Shi","year":"2021","unstructured":"Shi L et al (2021) Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. Nanoscale 13(24):10748\u201310764","journal-title":"Nanoscale"},{"key":"10835_CR68","unstructured":"Farhoudi-Sefidan-Jadid M, Alizadeh\u00b9 E, Fathi M (2024) Targeted delivery of silibinin via magnetic niosomal nanoparticles: potential application in treatment. Molecular Targets in Oncological and Hematological Disease Management: Innovations in Precision Medicine,: p. 8"},{"issue":"7","key":"10835_CR69","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/nu14071331","volume":"14","author":"A Mahmoudi","year":"2022","unstructured":"Mahmoudi A et al (2022) Investigation of the effect of Curcumin on protein targets in NAFLD using bioinformatic analysis. Nutrients 14(7):1331","journal-title":"Nutrients"},{"issue":"10","key":"10835_CR70","doi-asserted-by":"crossref","first-page":"e1008239","DOI":"10.1371\/journal.pcbi.1008239","volume":"16","author":"A Singhal","year":"2020","unstructured":"Singhal A et al (2020) Multiscale community detection in cytoscape. PLoS Comput Biol 16(10):e1008239","journal-title":"PLoS Comput Biol"},{"key":"10835_CR71","doi-asserted-by":"crossref","first-page":"735329","DOI":"10.3389\/fmicb.2021.735329","volume":"12","author":"L Hu","year":"2021","unstructured":"Hu L et al (2021) A novel network-based algorithm for predicting protein-protein interactions using gene ontology. Front Microbiol 12:735329","journal-title":"Front Microbiol"},{"key":"10835_CR72","doi-asserted-by":"crossref","unstructured":"Han X et al (2021) Bioinformatics analysis to screen key targets of Curcumin against colorectal Cancer and the correlation with Tumor-Infiltrating immune cells, vol 2021. Evidence\u2010Based Complementary and Alternative Medicine, p 9132608. 1","DOI":"10.1155\/2021\/9132608"},{"key":"10835_CR73","doi-asserted-by":"crossref","first-page":"100375","DOI":"10.1016\/j.hermed.2020.100375","volume":"23","author":"MMA Boojar","year":"2020","unstructured":"Boojar MMA, Boojar MMA, Golmohammad S (2020) Overview of Silibinin anti-tumor effects. J Herb Med 23:100375","journal-title":"J Herb Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10835-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:25:48Z","timestamp":1766895948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10835-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10835"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10835-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"737"}}